Clear Harbor Asset Management, LLC Iovance Biotherapeutics, Inc. Transaction History
Clear Harbor Asset Management, LLC
- $1.23 Billion
- Q4 2024
A detailed history of Clear Harbor Asset Management, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Clear Harbor Asset Management, LLC holds 23,550 shares of IOVA stock, worth $88,312. This represents 0.01% of its overall portfolio holdings.
Number of Shares
23,550
Previous 17,550
34.19%
Holding current value
$88,312
Previous $164,000
6.1%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding IOVA
# of Institutions
343Shares Held
247MCall Options Held
2.51MPut Options Held
3.5M-
Vanguard Group Inc Valley Forge, PA27.5MShares$103 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$91.6 Million24.02% of portfolio
-
Perceptive Advisors LLC New York, NY22.1MShares$82.9 Million5.46% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$79.6 Million0.0% of portfolio
-
State Street Corp Boston, MA12.2MShares$45.9 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $592M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...